Objective: The heart expresses angiotensin converting enzyme (ACE)-2 that makes it vulnerable to severe acute respiratory syndrome-coronavirus-2. Besides ACE inhibitors/angiotensin receptor blockers (ARBs) are used for cardiovascular diseases. Although no significant increase in the risk of coronavirus disease-2019 (COVID-19) infection and severity disease patients receving inhibitor/ARB therap...

INTRODUCTION The incidence of cough induced by angiotensin-converting enzyme (ACE) inhibitors has been reported to be 5%-20%, with less than half of affected patients requiring discontinuation due to persistent cough. However, the incidence in the local Asian population has not been studied. This study aimed to objectively evaluate the incidence of discontinuation of ACE inhibitors due to cough...

Shirin Antia [1], the Meyerson Distinguished Professor of Disability and Rehabilitation in the Department of Disability and Psychoeducational Studies [2], has been given the Lifetime Achievement Award by the Association of College Educators ? Deaf and Hard of Hearing [3]. The award recognizes the "distinguished career of an ACE-DHH member across teaching, research and service in the preparation...

Angiotensin-converting enzyme (ACE) inhibitors are the leading cause of a drug-induced angioedema. This occurrence is frequently underdiagnosed, but its relapse can be life-threatening. The authors' intention in reporting this clinical case is to sound a warning about reviewing attitudes and surveillance to try to improve patient perioperative safety.

Cardiotoxic effects account for a large proportion of the mortality arising from drug overdose, and many drugs can cause cardiovascular manifestations, which include effects on heart rate and blood pressure, electrocardiographic (ECG) abnormalities and arrhythmias (Table 1). This article discusses the cardiovascular management of toxicity with angiotensin-converting enzyme (ACE) inhibitors and ...

OBJECTIVE To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in patients with diabetic nephropathy. DATA SOURCES Medline, Embase, the Cochrane controlled trials register, conference proceedings, and contact with investigators. STUDY SELECTION Trials comparing ACE inhibitors or A...

Objective To evaluate the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists (AIIRAs) on renal outcomes and all cause mortality in patients with diabetic nephropathy. Data sources Medline, Embase, the Cochrane controlled trials register, conference proceedings, and contact with investigators. Study selection Trials comparing ACE inhibitors or AIIRA...

diabetes mellitus is a multifactorial disease. it has recently been shown that an insertion (i)/deletion (d) polymorphism exists in the angiotensin-converting enzyme (ace) gene that can affect the serum ace level. there are three genotypes: dd, di, and ii, with the ace level being highest in dd, intermediate in di, and lowest in ii. in the present investigation, 170 patients with type 2 diabete...

The results of recent randomized trials to test the influence of antioxidants on coronary-event rates and prognosis in patients with coronary-artery disease were disappointing. In none of these studies did the use of vitamin E improve prognosis. In contrast, treatment of coronary-artery disease with angiotensin-converting-enzyme (ACE) inhibitors reduced coronary-event rates and improved prognos...

treat acquired immunodeficiency syndrome [AIDS]) and against the angiotensin-converting enzyme (ACE) (to treat hypertension) are the only protease inhibitors approved by the FDA for therapeutic use (see Table 1). HIV-1 protease is an aspartic protease that is necessary for the processing of viral polypeptides late in the viral replicative cycle. Inhibition of this activity prevents formation of...